Bordetella bronchiseptica bronchitis

Papasian, Christopher J.; Downs, Nancy J.; Talley, R L; Romberger, D J; Hodges, Glenn R.

doi:10.1128/jcm.25.3.575-577.1987

Cited by 37 publications

(5 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It is transmitted by aerosol or droplet transmission to humans and has worldwide epidemiology. However, Bordetella bronchiseptica infection in humans is rare; the majority of cases involved exposure to pet or farm animals (1, 2, 6–8). Although the prevalence is thought to be the same worldwide, most human infections have been reported outside of the United States.…”

Section: Discussionmentioning

confidence: 99%

Bordetella bronchisepticainfection in pediatric lung transplant recipients

Ner

Ross

Horn

et al. 2003

Pediatric Transplantation

View full text Add to dashboard Cite

Bordetella bronchiseptica are small, pleomorphic Gram-negative coccobacilli which are commensal organisms in the upper respiratory tract of many wild and domestic animals ('kennel cough' in dogs). While it is common for health care providers to ask about exposure to ill family/friends, most do not routinely inquire about the health or immunization status of household pets. We report two cases of B. bronchiseptica pneumonia in lung transplant recipients [cystic fibrosis (CF); ages 10 and 15 yr; one male] who contracted B. bronchiseptica from pet dogs. We compared their course and outcome to four children (two CF, one congenital heart disease and one Duchenne's muscular dystrophy; four males, age range 6 months to 14 yr) with B. bronchiseptica cultured from the respiratory tract. Two of the four patients also acquired their illnesses from pet dogs and two from unknown sources. One lung transplant recipient expired from progressive respiratory failure. We conclude that B. bronchiseptica can cause serious infections in both immunosuppressed and immunocompetent children. We speculate that a detailed history of exposure to ill pets (particularly dogs), and the immunization status of all pets should be included in the routine evaluation of all pediatric transplant recipients.

show abstract

Section: Discussionmentioning

confidence: 99%

Bordetella bronchisepticainfection in pediatric lung transplant recipients

Ner

Ross

Horn

et al. 2003

Pediatric Transplantation

View full text Add to dashboard Cite

show abstract

“…A fourth identical course was necessary to eradicate the bacteria. Treatment of B. bronchiseptica bronchopulmonary infections is difficult, and relapses have been often described (10,20,36). A long duration of antibiotic therapy, especially in compromised patients, seems to be important for a definitive cure.…”

Section: Discussionmentioning

confidence: 99%

Human Bordetella bronchiseptica infection related to contact with infected animals: persistence of bacteria in host

et al. 1995

View full text Add to dashboard Cite

Within a period of 2 1/2 years, Bordetella bronchiseptica was isolated four times from a 79-year-old woman with bronchopneumonia. We have demonstrated by pulsed-field gel electrophoresis that this infection was related to contact with infected rabbits. The initial human B. bronchiseptica isolate had a phenotype characteristic of usual B. bronchiseptica clinical isolates; it produced toxin and adhesins, such as adenylate cyclasehemolysin, filamentous hemagglutinin, and pertactin, and was able to induce lethality in a murine respiratory model. By contrast, although the three successive human isolates produced adhesins, they did not express adenylate cyclase-hemolysin and were unable to induce lethality. This implies that adenylate cyclase-hemolysin is required to induce lethality. We suggest that B. bronchiseptica may persist in the host, with expression of adenylate cyclase-hemolysin being essential for the initiation of infection and expression of adhesins being essential for persistence.

show abstract

“…10 Tomando en cuenta la capacidad de invadir células epiteliales y fagocitos, es importante incluir dentro las opciones de antibióticos a usar, uno que alcance suficiente penetración intracelular. 16 En este caso, la paciente fue inicialmente tratada con cefotaxima, sin embargo tras el reporte del antibiograma y la poca mejoría clínica, se cambió a gentamicina, que resultó efectivo para el control de la infección.…”

Section: Discussionunclassified

Neumonía por Bordetella bronchiseptica en paciente con antecedente de linfoma pulmonar

Cob-Delgado

Jiménez-Camacho

Barquero

2021

AMC

View full text Add to dashboard Cite

Bordetella bronchiseptica es un cocobacilo Gram negativo patógeno de animales que, con poca frecuencia causa infecciones en seres humanos. La mayoría de casos registrados en la literatura están asociados con pacientes que presentan algún tipo de inmunosupresión. Este reporte de caso se refiere a una paciente femenina de 67 años con antecedentes de linfoma pulmonar, que recibió quimioterapia y radioterapia 16 años atrás, fue ingresada al Servicio de Medicina Interna del Hospital Tomás Casas Casajús con un diagnóstico de neumonía bacteriana, tras descartarse infección por Covid19. Unos días después, se aisló una B. brochiseptica de una muestra de esputo y con el reporte de la prueba sensibilidad a los antibióticos, se modificó la terapia de antibióticos que originalmente se había indicado, lo que se conlleva a una mejoría en el estado físico de la paciente. Sin embargo, debido a una aparente infección nosocomial la paciente se contagió de SARS-CO2 y falleció debido a las complicaciones causadas por el Covid19.

show abstract

Bordetella bronchiseptica bronchitis

Cited by 37 publications

References 11 publications

Bordetella bronchisepticainfection in pediatric lung transplant recipients

Bordetella bronchisepticainfection in pediatric lung transplant recipients

Human Bordetella bronchiseptica infection related to contact with infected animals: persistence of bacteria in host

Neumonía por Bordetella bronchiseptica en paciente con antecedente de linfoma pulmonar

Contact Info

Product

Resources

About